Canadian Natural Resources Limited (TSE:CNQ - Get Free Report) NYSE: CNQ Senior Officer Mark Anthony Overwater sold 8,260 shares of the stock in a transaction dated Thursday, June 19th. The stock was sold at an average price of C$46.44, for a total value of C$383,594.40.
Canadian Natural Resources Stock Performance
TSE:CNQ traded up C$0.04 during mid-day trading on Thursday, hitting C$46.04. The stock had a trading volume of 5,030,704 shares, compared to its average volume of 14,242,472. Canadian Natural Resources Limited has a twelve month low of C$34.92 and a twelve month high of C$52.15. The stock has a market cap of C$96.62 billion, a price-to-earnings ratio of 12.78, a PEG ratio of 0.53 and a beta of 1.89. The company's 50 day simple moving average is C$42.05 and its 200 day simple moving average is C$42.93. The company has a debt-to-equity ratio of 25.79, a quick ratio of 0.54 and a current ratio of 0.84.
Analysts Set New Price Targets
Several brokerages have recently weighed in on CNQ. Desjardins decreased their price objective on Canadian Natural Resources from C$51.00 to C$49.00 and set a "buy" rating for the company in a report on Tuesday, April 15th. Raymond James Financial upgraded Canadian Natural Resources from a "market perform" rating to an "outperform" rating and decreased their price objective for the company from C$52.00 to C$49.00 in a report on Wednesday, April 9th. Evercore ISI upgraded Canadian Natural Resources from a "hold" rating to a "strong-buy" rating in a report on Friday, March 7th. Wells Fargo & Company raised their price objective on Canadian Natural Resources from C$40.00 to C$42.00 in a report on Thursday, May 22nd. Finally, Scotiabank upgraded Canadian Natural Resources from a "sector perform" rating to an "outperform" rating and set a C$56.00 price objective for the company in a report on Wednesday, March 19th. Five research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Canadian Natural Resources currently has a consensus rating of "Moderate Buy" and an average target price of C$54.25.
View Our Latest Stock Analysis on Canadian Natural Resources
About Canadian Natural Resources
(
Get Free Report)
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canadian Natural Resources, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canadian Natural Resources wasn't on the list.
While Canadian Natural Resources currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.